OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

2.23
Delayed Data
As of Jul 06
 -0.025 / -1.11%
Today’s Change
1.74
Today|||52-Week Range
3.70
-2.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$53.5M

Company Description

OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company. It develops and commercializes new cancer therapies that address treatment resistance in cancer patients. It has developed a pipeline of late-stage product candidates that are designed to block the production of specific proteins that promote treatment resistance in cancer. The company operates through three product pipeline: custirsen, apatorsen and OGX-225. OncoGenex Pharmaceuticals was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA.

Contact Information

OncoGenex Pharmaceuticals, Inc.
19820 North Creek Parkway
Bothell Washington 98011
P:(425) 686-1500
Investor Relations:
(425) 686-1514

Employees

Shareholders

Individual stakeholders5.56%
Other institutional22.54%
Mutual fund holders13.14%

Top Executives

Scott Daniel CormackPresident, CEO, Secretary, Treasurer & Director
John A. BencichChief Financial Officer & Vice President
Patricia S. StewartVice President-Clinical Development
Cindy A. JacobsChief Medical Officer & Executive Vice President
Jaime WelchVP-Marketing & Corporate Communications

To view my watchlist

Not a member yet?

Sign up now for a free account